Literature DB >> 11320596

Endothelial cell activation following moderate traumatic brain injury.

R Balabanov1, H Goldman, S Murphy, G Pellizon, C Owen, J Rafols, P Dore-Duffy.   

Abstract

Traumatic brain injury (TBI) initiates a cascade of acute and chronic injury responses which include disturbances in the cerebrovasculature that may result in the activation of the microvascular endothelial development of a dysfunction endothelium. The present study examines endothelial cell (EC) activation in a percussion model of moderate TBI. The criteria for endothelial activation used in these studies was surface expression of a number of markers collectively termed endothelial activation antigens. Temporal induction of the major histocompatibility (MHC) class II molecules, E-selectin (CD62E), vascular cell adhesion molecule (VACM-1) (CD106) as well as altered expression of constitutively expressed intercellular adhesion molecule-1 (ICAM-1) (CD54), the glucose transporter protein (glut-1), the transferrin receptor (tfR) (CD71), and MHC class I molecules was examined at various times following impact. Induction of E-selectin and increased expression of ICAM-1 was seen by 2 h post-impact (PI) and was sustained through 24 h PI. Decreased expression of immunologically reactive glut-1 and tfR was observed by 2-4 h PI and remained low up to 24 h PI. No induction of VCAM-1, MHC class II molecules or altered constitutive expression or MHC class I molecules was seen. Changes in EC activation were observed predominantly at the site of impact and were diminished temporarily. These results indicate that mild concussive injury to the brain results in activation of the endothelium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320596     DOI: 10.1179/016164101101198514

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  23 in total

1.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

2.  Impact of moderate blast exposures on thrombin biomarkers assessed by calibrated automated thrombography in rats.

Authors:  Victor Prima; Victor L Serebruany; Artem Svetlov; Ronald L Hayes; Stanislav I Svetlov
Journal:  J Neurotrauma       Date:  2013-10-04       Impact factor: 5.269

Review 3.  Response of the cerebral vasculature following traumatic brain injury.

Authors:  Arjang Salehi; John H Zhang; Andre Obenaus
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-05       Impact factor: 6.200

Review 4.  Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury.

Authors:  Dan Shlosberg; Mony Benifla; Daniela Kaufer; Alon Friedman
Journal:  Nat Rev Neurol       Date:  2010-06-15       Impact factor: 42.937

Review 5.  Smooth muscle phenotype switching in blast traumatic brain injury-induced cerebral vasospasm.

Authors:  Eric S Hald; Patrick W Alford
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829

6.  Impairment of cerebrovascular reactivity in response to hypercapnic challenge in a mouse model of repetitive mild traumatic brain injury.

Authors:  Cillian E Lynch; Maxwell Eisenbaum; Moustafa Algamal; Matilde Balbi; Scott Ferguson; Benoit Mouzon; Nicole Saltiel; Joseph Ojo; Ramon Diaz-Arrastia; Mike Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-13       Impact factor: 6.200

Review 7.  Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets.

Authors:  Mathew B Potts; Seong-Eun Koh; William D Whetstone; Breset A Walker; Tomoko Yoneyama; Catherine P Claus; Hovhannes M Manvelyan; Linda J Noble-Haeusslein
Journal:  NeuroRx       Date:  2006-04

Review 8.  Adhesion molecules in CNS disorders: biomarker and therapeutic targets.

Authors:  Qingyi Ma; Sheng Chen; Damon Klebe; John H Zhang; Jiping Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-05-01       Impact factor: 4.388

9.  Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury.

Authors:  S-F Chen; C-W Hsu; W-H Huang; J-Y Wang
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

10.  Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients.

Authors:  Shawn G Rhind; Naomi T Crnko; Andrew J Baker; Laurie J Morrison; Pang N Shek; Sandro Scarpelini; Sandro B Rizoli
Journal:  J Neuroinflammation       Date:  2010-01-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.